M'bouye '. Doucoure
Bamako, BKO, Mali
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mosquito direct skin feeding bioassay: 15 years of experience and a standardised approach in Mali.
Journal: Malaria journal
Published: September 05, 2025
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.
Journal: The New England journal of medicine
Published: April 26, 2024
Normal Clinical Laboratory Ranges by Age and Sex, and Impact on Study Screening Outcomes in Rural Mali.
Journal: The American journal of tropical medicine and hygiene
Published: October 18, 2023
Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial.
Journal: The Lancet. Infectious diseases
Published: January 30, 2023
Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali.
Journal: The New England journal of medicine
Published: November 01, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali.
Journal: The Journal of infectious diseases
Published: July 21, 2021
Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 18, 2021
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study.
Journal: medRxiv : the preprint server for health sciences
Published: May 05, 2021
SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali.
Journal: medRxiv : the preprint server for health sciences
Published: March 24, 2021
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.
Journal: The Lancet. Infectious diseases
Published: January 17, 2018
Last Updated: 09/26/2026